ZSAN
$0.63
Zosano Pharma
($.01)
(1.26%)
ZSAN
Earnings Whisper ®
N/A
3rd Quarter September 2021
Consensus:  ($0.07)
Revenue:  $1.09 Mil
Tuesday
Nov 9
After the close
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when ZSAN reports earnings?
Beat
Meet
Miss

Where is ZSAN's stock price going from here?
Up
Flat
Down
Stock chart of ZSAN
Analysts
Summary of analysts' recommendations for ZSAN
Score
Grade
Pivots
Resistance
$0.66
$0.65
$0.64

$0.63

Support
$0.63
$0.62
$0.61
Tweet
Growth
Description
Zosano Pharma Corporation is a biopharmaceutical company. It is engaged in developing a transdermal micro needle patch system to deliver formulations of existing drugs through the skin for the treatment of a variety of indications. The Company's lead product candidates include Weekly ZP-PTH for severe osteoporosis; ZP-Glucagon for severe hypoglycemia and ZP-Triptan, for migraine. Zosano Pharma Corporation is headquartered in Fremont, California.
Peers
Vertex PharmaceuticalsUltragenyx PharmaceuticalRegeneron PharmaceuticalsBioMarin PharmaceuticalBristol-Myers SquibbInterCeptMerck & Co.Eli LillyZoetisPfizer